Related Experiment Video
Updated: Apr 26, 2026

Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor LATS Biosensor
Published on: September 13, 2018
Hippo-YAP signaling pathway: A new paradigm for cancer therapy
Yanlei Ma1, Yongzhi Yang1, Feng Wang1
1Department of GI Surgery, Shanghai Tenth People's Hospital Affiliated with Tongji University, Shanghai, People's Republic of China.
Abstract:
In the past decades, the Hippo signaling pathway has been delineated and shown to play multiple roles in the control of organ size in both Drosophila and mammals. In mammals, the Hippo pathway is a kinase cascade leading from Mst1/2 to YAP and its paralog TAZ. Several studies have demonstrated that YAP/TAZ is a candidate oncogene and that other members of the Hippo pathway are tumor suppressive genes. The dysregulation of the Hippo pathway has been observed in a variety of cancers. This review chronicles the recent progress in elucidating the function of Hippo signaling in tumorigenesis and provide a rich source of potential targets for cancer therapy.
Insights
The Hippo signaling pathway regulates organ size and is implicated in cancer. Its dysregulation is observed in various cancers, making it a target for new cancer therapies.
Area of Science:
- Molecular Biology
- Cell Signaling
- Oncology
Background:
- The Hippo signaling pathway controls organ size in mammals and Drosophila.
- It involves a kinase cascade from Mst1/2 to YAP and TAZ.
- YAP/TAZ are oncogenes, while other Hippo pathway members are tumor suppressors.
Purpose of the Study:
- To review recent advances in understanding Hippo signaling's role in tumorigenesis.
- To identify potential therapeutic targets for cancer treatment.
Main Methods:
- Literature review of studies on Hippo signaling and cancer.
- Analysis of the Hippo pathway's function in tumorigenesis.
Main Results:
- Hippo pathway dysregulation is linked to various cancers.
- YAP/TAZ act as oncogenes, promoting tumor growth.
- Other Hippo pathway components exhibit tumor-suppressive functions.
Conclusions:
- The Hippo signaling pathway is a critical regulator in cancer development.
- Targeting the Hippo pathway offers promising avenues for novel cancer therapies.
More Related Videos
10:32Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
Published on: December 19, 2019
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
Related Concept Videos
Hedgehog Signaling Pathway
Hedgehog Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
PI3K/mTOR/AKT Signaling Pathway